cbdMD (YCBD) Stock Price, News & Analysis

Company Overview

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.

Key Stats

• Today's Range: $0.32 to $0.37
• 50-Day Range: N/A
• 52-Week Range: $0.31 to $1.73
• Volume: 175,205 shs
• Average Volume: 211,233 shs
• Market Capitalization: $1.35 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

cbdMD Stock Analysis - MarketRank™

cbdMD scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for cbdMD.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of cbdMD is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of cbdMD is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

cbdMD has a P/B Ratio of 0.11. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.21% of the float of cbdMD has been sold short.

Short Interest Ratio / Days to Cover

cbdMD has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in cbdMD has recently decreased by 6.21%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

cbdMD does not currently pay a dividend.

Dividend Growth

cbdMD does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.21% of the float of cbdMD has been sold short.

Short Interest Ratio / Days to Cover

cbdMD has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in cbdMD has recently decreased by 6.21%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: N/A

News Sentiment

cbdMD has a news sentiment score of -0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Business Services companies.

Search Interest

2 people have searched for YCBD on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, cbdMD insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.95% of the stock of cbdMD is held by insiders.

Percentage Held by Institutions

Only 7.18% of the stock of cbdMD is held by institutions.

YCBD Stock Analysis - Frequently Asked Questions

How have YCBD shares performed this year?

cbdMD's stock was trading at $0.59 at the beginning of the year. Since then, YCBD stock has decreased by 39.0% and is now trading at $0.36.
View the best growth stocks for 2024 here.

How were cbdMD's earnings last quarter?

cbdMD, Inc. (NYSEAMERICAN:YCBD) issued its earnings results on Thursday, December, 16th. The company reported ($3.15) EPS for the quarter, missing analysts' consensus estimates of ($2.03) by $1.13. The company earned $9.79 million during the quarter. cbdMD had a negative net margin of 96.00% and a negative trailing twelve-month return on equity of 350.55%.

When did cbdMD's stock split?

cbdMD shares reverse split before market open on Tuesday, April 25th 2023. The 1-45 reverse split was announced on Tuesday, April 25th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

How do I buy shares of cbdMD?

Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of cbdMD own?

Based on aggregate information from My MarketBeat watchlists, some other companies that cbdMD investors own include Village Farms International (VFF), Tilray (TLRY), NVIDIA (NVDA), Roku (ROKU), Organigram (OGI), Bristol-Myers Squibb (BMY) and Bionano Genomics (BNGO).

Company Calendar

• Last Earnings: 12/16/2021
• Today: 12/22/2024
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Business Services
• Industry: Toilet preparations
• Sub-Industry: Consumer Goods
• Current Symbol: NYSEAMERICAN:YCBD
• CUSIP: N/A
• CIK: 1644903
• Web: www.cbdmd.com
• Phone: (704) 445-3060
• Fax: N/A
• Employees: 90
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($11.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-22,940,000.00
• Net Margins: -96.00%
• Pretax Margin: -96.00%
• Return on Equity: -350.55%
• Return on Assets: -130.17%

Debt

• Debt-to-Equity Ratio: 0.46
• Current Ratio: 0.93
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: $24.16 million
• Price / Sales: 0.06
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.16 per share
• Price / Book: 0.11

Miscellaneous

• Outstanding Shares: 3,760,000
• Free Float: 3,727,000
• Market Cap: $1.35 million
• Optionable: Not Optionable
• Beta: 1.98